Sources | Names Used |
---|---|
CTRPv2 | JQ-1:navitoclax (2:1 mol/mol) |
PharmacoGx | JQ-1:navitoclax (2:1 mol/mol) |
Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | RPS6KA4 | CTRPv2 | pan-cancer | AAC | -0.1 | 0.007 |
mRNA | TMEM256 | CTRPv2 | pan-cancer | AAC | -0.092 | 0.007 |
mRNA | TIMM23 | CTRPv2 | pan-cancer | AAC | -0.093 | 0.007 |
mRNA | KCNN2 | CTRPv2 | pan-cancer | AAC | 0.095 | 0.007 |
mRNA | TNFAIP8L2 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.007 |
mRNA | CDK13 | CTRPv2 | pan-cancer | AAC | 0.092 | 0.007 |
mRNA | NEFH | CTRPv2 | pan-cancer | AAC | 0.093 | 0.007 |
mRNA | ZCCHC3 | CTRPv2 | pan-cancer | AAC | 0.1 | 0.007 |
mRNA | CNOT9 | CTRPv2 | pan-cancer | AAC | 0.099 | 0.007 |
mRNA | ARPP21 | CTRPv2 | pan-cancer | AAC | 0.092 | 0.007 |